Conclusion: In conjunction with psychosocial interventions, these findings support the use of oral naltrexone at 50 mg/d and acamprosate as first-line pharmacotherapies for alcohol use disorder.
PubMed 37934220 ↗Naltrexone
Also known as Low Dose Naltrexone, LDN, Revia
The short answer. More people than not who report on Naltrexone say it helped (67% of 28). It is most often used for pain & inflammation: 88% of 8 reports say that improved. It is well studied — 317 meta-analyses on PubMed.
From 79 mentions in total — the rest didn't say how it went and aren't counted.
What Naltrexone does, according to users
Of the people who reported each effect, the share who said it got better.
5 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 317 meta-analyses on PubMed ↗ · 926 randomized trials ↗
Conclusion: Tirzepatide was effective in remission of obstructive sleep apnea syndrome and metabolic dysfunction-associated steatohepatitis. These results support the need to individualize the selection of OMMs.
PubMed 41039116 ↗Conclusion: In adults with overweight and obesity, phentermine-topiramate and GLP-1 receptor agonists proved the best drugs in reducing weight; of the GLP-1 agonists, semaglutide might be the most effective.
PubMed 38582569 ↗Conclusion: Obesity drugs produce variable weight loss at one year, with larger benefits generally accompanied by greater harms and discontinuation. Most agents do not improve quality of life meaningfully and few show cardiovascular benefits. Decisions in clinical practice should consider trade-offs between benefits and harms within the context of shared decision making.
PubMed 42419792 ↗536 human trials on ClinicalTrials.gov test Naltrexone — 381 completed, 32 recruiting now. See all on ClinicalTrials.gov ↗
- Pharmacological and Behavioral Treatment After Bariatric Surgery · Obesity · 2026
- Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences · Naltrexone, Placebo · 2026
- Promoting Alcohol Treatment Engagement Post-hospitalization · Alcohol Use Disorder · 2026
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
13 recalls of products named for Naltrexone. Most recent:
- 2022-06-15 · Class II: cGMP deviations: Temperature abuse record ↗
- 2020-04-22 · Class II: Lack of Processing Control record ↗
- 2020-02-05 · Class II: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
32,067 adverse-event reports mention Naltrexone. Most often reported:
- Injection site reaction · 4,417
- Injection site pain · 3,189
- Nausea · 2,243
- Fatigue · 1,974
- Alcoholism · 1,956
- Injection site mass · 1,931
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Naltrexone E — an unlikely cause of liver injury. LiverTox entry ↗
NIH has funded 180 research projects with Naltrexone in the title, $312,223,304 in total (1985–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Naltrexone ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I tried to quit drinking hundreds of times... I tried a new method and it was super easy and a major life upgrade. It's simple, you take Naltrexone every morning... you don't get that horrific 'chasing the dragon' effect.”
“LDN didn't work for me and made me miserable after the first few doses.”
“I took low dose Naltrexone 4.5mg and after 30 years of drinking daily did not have cravings when I quit 8 months ago. Game changer!”
“The low dose naltrexone was the game changer for my fibromyalgia pain.”
Top discussions (5)
Other options for pain & inflammation
Sources
- User reports: 79 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate